MG
ABBV icon

Mather Group’s AbbVie ABBV Stock Holding History

Mather Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.53M Sell
34,635
-355
-1% -$78.7K 0.08% 99
2025
Q4 		$7.99M Buy
34,990
+102
+0.3% +$23.2K 0.08% 92
2025
Q3 		$8.08M Buy
34,888
+1,357
+4% +$276K 0.08% 91
2025
Q2 		$6.22M Buy
33,531
+3,153
+10% +$586K 0.07% 105
2025
Q1 		$6.36M Buy
30,378
+644
+2% +$125K 0.07% 102
2024
Q4 		$5.28M Buy
29,734
+950
+3% +$175K 0.07% 108
2024
Q3 		$5.68M Sell
28,784
-32,701
-53% -$6.1M 0.07% 107
2024
Q2 		$11.2M Buy
61,485
+34,287
+126% +$5.68M 0.14% 77
2024
Q1 		$4.21M Sell
27,198
-12,300
-31% -$2.12M 0.07% 104
2023
Q4 		$6.12M Buy
39,498
+1,787
+5% +$261K 0.1% 84
2023
Q3 		$5.62M Buy
37,711
+2,036
+6% +$299K 0.1% 81
2023
Q2 		$4.81M Buy
35,675
+857
+2% +$126K 0.08% 99
2023
Q1 		$5.55M Buy
34,818
+8,355
+32% +$1.28M 0.1% 82
2022
Q4 		$4.28M Sell
26,463
-298
-1% -$45.7K 0.08% 90
2022
Q3 		$3.59M Buy
26,761
+3,356
+14% +$482K 0.08% 91
2022
Q2 		$3.58M Buy
23,405
+410
+2% +$62.6K 0.08% 88
2022
Q1 		$3.73M Buy
+22,995
New +$3.34M 0.07% 83
2020
Q4 		– Sell
-18,206
Closed -$1.59M – 250
2020
Q3 		$1.59M Buy
18,206
+641
+4% +$60.3K 0.06% 68
2020
Q2 		$1.73M Buy
+17,565
New +$1.55M 0.08% 64

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mather Group's ABBV Position: Q1 2026 in Review

Mather Group reduced its AbbVie (ABBV) stake by 1% in Q1 2026, selling an estimated $78.7K and leaving 34,635 shares worth $7.53M. The position accounts for 0.08% of the portfolio, ranked #99.

Mather Group first reported a position in ABBV in Q2 2020 and has held it in 19 quarters since. The position peaked at $11.2M in Q2 2024. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Mather Group held 34,635 shares of AbbVie worth $7.53M as of Q1 2026.
  • Mather Group sold 355 AbbVie shares in Q1 2026, an estimated $78.7K.
  • AbbVie made up 0.08% of Mather Group's portfolio in Q1 2026, its #99 holding.
  • Mather Group first reported a position in AbbVie in Q2 2020 and has held it in 19 quarters since.
  • Mather Group's AbbVie position peaked at $11.2M in Q2 2024.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Mather Group's 13F filing for Q1 2026, filed 13 Apr 2026.